Smoking, smoking cessation, and risk for type 2 diabetes mellitus: A cohort study

Annals of Internal Medicine

Volumn 152, Issue 1, 2010, Pages 10-17

  Yeh, Hsin Chieh ^a   Duncan, Bruce B ^b   Schmidt, Maria Inês ^b   Wang, Nae Yuh ^a   Brancati, Frederick L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING; SMOKING CESSATION; WEIGHT CHANGE;

EID: 74849090712     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-1-201001050-00005     Document Type: Article

References (29)

1. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007; 298:2654-64. [PMID: 18073361]
2. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med. 2007;167:1676-85. [PMID: 17698692]
3. O'Hara P, Connett JE, Lee WW, Nides M, Murray R, Wise R. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol. 1998;148:821-30. [PMID: 9801011]
4. Balkau B, Vierron E, Vernay M, Born C, Arondel D, Petrella A, et al; DESIR Study Group. The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study. Eur J Cardiovasc Prev Rehabil. 2006;13:334-40. [PMID: 16926661]
5. Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, Antó JM, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet. 2005;365:1629-35; discussion 1600-1. [PMID: 15885295]
6. Wannamethee SG, Shaper AG, Perry IJ; British Regional Heart Study. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590-5. [PMID: 11522704]
7. Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil. 2007;14:244-9. [PMID: 17446803]
8. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129:687-702. [PMID: 2646917]
9. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982; 36:936-42. [PMID: 7137077]
10. Operations Manual No. 2: Cohort Component Procedures, Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, Univ of North Carolina; 1987. 11. Operations Manual No. 11: Sitting Blood Pressure, Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, Univ of North Carolina; 1987.
11. Nägele U, Hägele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-74. [PMID: 6716056]
12. Warnick GR, Benderson JM, Albers JJ. Quantitation of high-density lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation [Abstract]. Clin Chem. 1982;28:1574.
13. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study Investigators. Inflammation markers predict increased weight gain in smoking quitters. Obes Res. 2003;11:1339-44. [PMID: 14627754]
14. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes. 2003;52:1799-805. [PMID: 12829649]
15. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-41.
16. Efron B. Efficiency of Cox's likelihood function for censored data. J Am Stat Assoc. 1977;72:557-65.
17. Paynter NP, Yeh HC, Voutilainen S, Schmidt MI, Heiss G, Folsom AR, et al. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol. 2006; 164:1075-84. [PMID: 16982672]
18. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28:1472-9. [PMID: 15920070]
19. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56:2910-8. [PMID: 17848624]
20. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study Investigators. Inflammation markers predict increased weight gain in smoking quitters. Obes Res. 2003;11:1339-44. [PMID: 14627754]
21. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2006;103:10741-6. [PMID: 16818881]
22. Ferrara CM, Kumar M, Nicklas B, McCrone S, Goldberg AP. Weight gain and adipose tissue metabolism after smoking cessation in women. Int J Obes Relat Metab Disord. 2001;25:1322-6. [PMID: 11571594]
23. Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006;26:28-40. [PMID: 16239592]
24. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008; 87:801-9. [PMID: 18400700]
25. Rehani K, Scott DA, Renaud D, Hamza H, Williams LR, Wang H, et al. Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. Biochim Biophys Acta. 2008; 1783:375-82. [PMID: 18178163]
26. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372-7. [PMID: 12033743]
27. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF. Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol. 2007;147:28-34. [PMID: 17177960]
28. Liu RH, Kurose T, Matsukura S. Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats. Metabolism. 2001;50:79-85. [PMID: 11172479]
29. O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, et al. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med. 2006;166:667-74. [PMID: 16567607]